GMED - Globus Medical Inc. (GMED) Q4 2023 Earnings Call Transcript
2024-02-20 23:01:12 ET
Globus Medical, Inc. (GMED)
Q4 2023 Earnings Conference Call
February 20, 2024 4:30 PM ET
Company Participants
Brian Kearns - Senior Vice President, Business Development and Investor Relations
Daniel Scavilla - President and Chief Executive Officer
Keith Pfeil - Chief Operating Officer and Chief Financial Officer
Conference Call Participants
Vikramjeet Chopra - Wells Fargo Securities
Steven Lichtman - Oppenheimer
Matt Blackman - Stifel
Shagun Singh - RBC Capital Markets
David Saxon - Needham & Company
Matthew Miksic - Barclays Bank
Matthew O’Brien - Piper Sandler & Co.
Matthew Taylor - Jefferies
Ryan Zimmerman - BTIG
Jason Wittes - ROTH MKM Partners
Craig Bijou - Bank of America Merrill Lynch
Caitlin Cronin - Canaccord
Richard Newitter - Truist Securities
Andrew Ranieri - Morgan Stanley
Presentation
Operator
Thank you for standing by, and welcome to the Globus Medical’s Fourth Quarter and Full Year 2023 Earnings Call. [Operator Instructions]. Please be advised that today’s conference is being recorded.
I will now turn the call over to your first speaker today, Brian Kearns, Senior Vice President of Business Development and Investor Relations. Please go ahead.
Brian Kearns
Thank you, Victor, and thank you, everyone, for being with us today. Joining today's call for Globus Medical will be Dan Scavilla, President and CEO; and Keith Pfeil, Chief Operating and Chief Financial Officer. This review is being made available via webcast accessible through Investor Relations section of the Globus Medical website at www.globusmedical.com.
Before we begin, let me remind that some of the statements made during this review are or may be considered forward-looking statements. Our Form 10-K for the 2023 fiscal year and our subsequent filings with the Securities and Exchange Commission identify certain factors that could cause our actual results to differ materially from those projected in any forward-looking statements made today....
Globus Medical, Inc. (GMED) Q4 2023 Earnings Call Transcript